Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

India · Delayed Price · Currency is INR

513.20

+5.40 (1.06%)

Aug 31, 2026, 3:29 PM IST

Dr. Agarwal's Health Care Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	22,067	20,801	17,110	13,322	10,180	6,961
Revenue Growth	22.94%	21.57%	28.44%	30.86%	46.25%	47.73%
Gross Profit	9,623	8,997	7,244	5,658	4,321	2,936
Operating Income	3,204	2,932	2,300	1,919	1,441	846.92
Net Income	1,484	1,332	834.6	830.6	940.97	376.94
Earnings Per Share	4.65	4.18	2.78	3.13	4.00	1.83
EPS Growth	41.75%	50.36%	-11.18%	-21.75%	118.58%	-

Revenue by Geography

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	18,707	15,376	11,618	8,734	5,635
outside India	2,094	1,734	1,704	1,446	1,326
Total	20,801	17,110	13,322	10,180	6,961

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	2,838	2,838	5,147	5,823	1,606	996.21
Total Debt	10,662	10,662	9,609	9,665	8,573	6,333
Net Cash (Debt)	-7,824	-7,824	-4,463	-3,843	-6,967	-5,337
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-24.53	-24.58	-14.88	-14.49	-29.55	-25.93

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	5,190	3,571	3,460	2,331	1,643
Capital Expenditures	-	-4,480	-3,087	-2,309	-1,566	-702.39
Free Cash Flow	-	710.4	484.8	1,151	765.33	940.89
Free Cash Flow Growth	-	46.53%	-57.88%	50.38%	-18.66%	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	43.61%	43.25%	42.34%	42.48%	42.45%	42.18%
Operating Margin	14.52%	14.10%	13.44%	14.41%	14.15%	12.17%
Pretax Margin	12.24%	11.95%	9.34%	10.55%	8.21%	8.15%
Profit Margin	6.72%	6.40%	4.88%	6.24%	9.24%	5.42%
FCF Margin	-	3.42%	2.83%	8.64%	7.52%	13.52%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 1, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	110.40	96.70	168.75	-	-	-
Forward PE	78.27	76.32	121.98	-	-	-
P/FCF Ratio	228.99	181.30	290.50	-	-	-
PS Ratio	7.37	6.19	8.23	-	-	-